The article focuses on the treatment of bladder cancer. Topics discussed include studies analyzing whole transcriptome expression data and unsupervised analytical methods; type of bladder cancers such as basal and luminal molecular subtypes; and clinical value analyzing prognostic or predictive biomarkers in the same.